, BCA assay, bicinchoninic acid assay
, N-cyclohexyl-N?-(4-iodophenyl)urea
,
, CV, coefficient of variance
,
,
, DSF, differential scanning fluorimetry; EET, epoxyeicosatrienoic acid
, EpFA, epoxy fatty acid
, FCS, fetal calf serum; FDP, fluorescein diphosphate
, FXR, farnesoid X receptor; HTS, highthroughput screening; IS, internal standard; ITC, isothermal titration calorimetry
,
, ORF, open reading frame; PGE2, prostaglandin E2, PPAR, peroxisome proliferator-activated receptor; RLU, relative light units
, ROS, reactive oxygen species; RXR, retinoid X receptor
sodium dodecyl sulfate; sEH, soluble epoxide hydrolase; sEH-H, C-terminal/hydrolase domain of sEH; sEHI, inhibitors of the C-terminal domain of sEH; sEH-P, N-terminal/phosphatase domain of sEH ,
, -carboxyethyl)phosphine, TCEP, issue.2
,
,
The Telltale Structures of Epoxide Hydrolases, Drug Metab. Rev, vol.35, issue.4, pp.365-383, 2003. ,
Soluble Epoxide Hydrolase as a Therapeutic Target for Pain, Inflammatory and Neurodegenerative Diseases, Pharmacol. Ther, vol.180, pp.62-76, 2017. ,
Modulation of Mitochondrial Dysfunction and Endoplasmic Reticulum Stress Are Key Mechanisms for the Wide-Ranging Actions of Epoxy Fatty Acids and Soluble Epoxide Hydrolase Inhibitors, Prostaglandins Other Lipid Mediators, vol.133, pp.68-78, 2017. ,
Pharmacodynamics and Adverse Event Profile of GSK2256294, a Novel Soluble Epoxide Hydrolase Inhibitor, Br. J. Clin. Pharmacol, vol.81, issue.5, pp.971-979, 2016. ,
The N-Terminal Domain of Mammalian Soluble Epoxide Hydrolase Is a Phosphatase, Proc. Natl. Acad. Sci. U. S. A, vol.100, issue.4, pp.1552-1557, 2003. ,
The Soluble Epoxide Hydrolase Encoded by EPXH2 Is a Bifunctional Enzyme with Novel Lipid Phosphate Phosphatase Activity, Proc. Natl. Acad. Sci. U. S. A, vol.100, issue.4, pp.1558-1563, 2003. ,
Lipid Sulfates and Sulfonates Are Allosteric Competitive Inhibitors of the N-Terminal Phosphatase Activity of the Mammalian Soluble Epoxide Hydrolase, Biochemistry, vol.44, issue.36, pp.12179-12187, 2005. ,
Role of Soluble Epoxide Hydrolase Phosphatase Activity in the Metabolism of Lysophosphatidic Acids, Biochem. Biophys. Res. Commun, vol.2012, issue.4, pp.796-800 ,
Lysophosphatidic Acids Are New Substrates for the Phosphatase Domain of Soluble Epoxide Hydrolase, J. Lipid Res, vol.53, issue.3, pp.505-512, 2012. ,
Proton Shuttles and Phosphatase Activity in Soluble Epoxide Hydrolase, J. Am. Chem. Soc, vol.129, issue.2, pp.387-394, 2007. ,
Phosphatase Activity of Soluble Epoxide Hydrolase, Prostaglandins Other Lipid Mediators, vol.133, pp.88-92, 2017. ,
Role of Phosphatase Activity of Soluble Epoxide Hydrolase in Regulating Simvastatin-Activated Endothelial Nitric Oxide Synthase, Sci. Rep, vol.5, p.13524, 2015. ,
Effects of Human Soluble Epoxide Hydrolase Polymorphisms on Isoprenoid Phosphate Hydrolysis, Biochem. Biophys. Res. Commun, vol.341, issue.1, pp.254-260, 2006. ,
Soluble Epoxide Hydrolase as an Anti-Inflammatory Target of the Thrombolytic Stroke Drug SMTP-7, J. Biol. Chem, issue.52, pp.35826-35838, 2014. ,
Development of an HTS Assay for EPHX2 Phosphatase Activity and Screening of Nontargeted Libraries, Anal. Biochem, vol.434, issue.1, pp.105-111, 2013. ,
Bacterial Expression and HTS Assessment of Soluble Epoxide Hydrolase Phosphatase, J. Biomol. Screening, vol.21, issue.7, pp.689-694, 2016. ,
Anions of Protected Cyanohydrins as Acyl Carbanion Equivalents and Their Use in a New Synthesis of Ketones, J. Am. Chem. Soc, vol.93, issue.20, pp.5286-5287, 1971. ,
Utilization of Operational Schemes for Analog Synthesis in Drug Design, J. Med. Chem, issue.10, pp.1006-1011, 1972. ,
Binding of Alkylurea Inhibitors to Epoxide Hydrolase Implicates Active Site Tyrosines in Substrate Activation, J. Biol. Chem, issue.20, pp.15265-15270, 2000. ,
Halogen?Aromatic ? Interactions Modulate Inhibitor Residence Times, Angew. Chem., Int. Ed, vol.57, issue.24, pp.7220-7224, 2018. ,
10-Iodo-11H-Indolo[3,2-c]Quinoline-6-Carboxylic Acids Are Selective Inhibitors of DYRK1A, J. Med. Chem, issue.7, pp.3131-3143, 2015. ,
Successful Generation of Structural Information for Fragment-Based Drug Discovery. Drug Discovery Today, vol.20, pp.1104-1111, 2015. ,
Inhibition of the Soluble Epoxide Hydrolase by Tyrosine Nitration, J. Biol. Chem, issue.41, pp.28156-28163, 2009. ,
Complementary Screening Techniques Yielded Fragments That Inhibit the Phosphatase Activity of Soluble Epoxide Hydrolase, ChemMedChem, vol.6, issue.12, pp.2146-2149, 2011. ,
Dar'in, D.; Krasavin, M. Discovery of Polar Spirocyclic Orally Bioavailable Urea Inhibitors of Soluble Epoxide Hydrolase, Bioorg. Chem, vol.80, pp.655-667, 2018. ,
Protein Production by Auto-Induction in High Density Shaking Cultures, Protein Expression Purif, vol.41, issue.1, pp.207-234, 2005. ,
Cress and Potato Soluble Epoxide Hydrolases: Purification, Biochemical Characterization, and Comparison to Mammalian Enzymes, Arch. Biochem. Biophys, vol.378, issue.2, pp.321-332, 2000. ,
Toxicology in the Fast Lane: Application of High-Throughput Bioassays to Detect Modulation of Key Enzymes and Receptors, Environ. Health Perspect, vol.117, issue.12, pp.1867-1872, 2009. ,
Development of a High-Throughput Screen for Soluble Epoxide Hydrolase Inhibition, Anal. Biochem, vol.355, issue.1, pp.71-80, 2006. ,
The Use of Differential Scanning Fluorimetry to Detect Ligand Interactions That Promote Protein Stability, Nat. Protoc, vol.2, issue.9, pp.2212-2221, 2007. ,
Decision Making in Xia2, Acta Crystallogr., Sect. D: Biol. Crystallogr, vol.69, issue.7, pp.1260-1273, 2013. ,
Overview of the CCP4 Suite and Current Developments, Acta Crystallogr., Sect. D: Biol. Crystallogr, vol.67, issue.4, pp.235-242, 2011. ,
An Introduction to Data Reduction: Space-Group Determination, Scaling and Intensity Statistics, Acta Crystallogr., Sect. D: Biol. Crystallogr, vol.67, issue.4, pp.282-292, 2011. ,
, J. Appl. Crystallogr, vol.40, issue.4, pp.658-674, 2007.
A Comprehensive Python-Based System for Macromolecular Structure Solution, Acta Crystallogr., Sect. D: Biol. Crystallogr, vol.66, issue.2, pp.213-221, 2010. ,
Features and Development of Coot, Acta Crystallogr., Sect. D: Biol. Crystallogr, vol.66, issue.4, pp.486-501, 2010. ,
Electronic Ligand Builder and Optimization Workbench (ELBOW): A Tool for Ligand Coordinate and Restraint Generation, Acta Crystallogr., Sect. D: Biol. Crystallogr, vol.65, issue.10, pp.1074-1080, 2009. ,
Towards Automated Crystallographic Structure Refinement with phenix.ref ine, Acta Crystallogr., Sect. D: Biol. Crystallogr, vol.2012, issue.4, pp.352-367 ,
In Vitro Pharmacological Evaluation of Multitarget Agents for Thromboxane Prostanoid Receptor Antagonism and COX-2 Inhibition, Pharmacol. Res, vol.103, pp.132-143, 2016. ,
Designing Multitarget Anti-Inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors, ChemMedChem, vol.2012, issue.9, pp.1647-1660 ,
Carnosic Acid and Carnosol, Phenolic Diterpene Compounds of the Labiate Herbs Rosemary and Sage, Are Activators of the Human Peroxisome Proliferator-Activated Receptor Gamma, Planta Med, vol.72, issue.10, pp.881-887, 2006. ,
DrugBank Screening Revealed Alitretinoin and Bexarotene as Liver X Receptor Modulators, Bioorg. Med. Chem. Lett, issue.5, pp.1193-1198, 2017. ,
Nonacidic Farnesoid X Receptor Modulators, J. Med. Chem, vol.2017, issue.16, pp.7199-7205 ,